LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
WHWK
Whitehawk Therapeutics Inc
There isn't enough reported data to score WHWK yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
WHWK Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
WHWK's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
WHWK PE Valuation
WHWK has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
WHWK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect WHWK's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over WHWK on earnings quality, reporting a profit while its opponent remains loss making.
WHWK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.89 | -1554% |
| Q2 2026 | -$1.92 | -$1.85 |
| Q1 2026 | -$2.48 | -1753% |
| Q4 2025 | -$0.33 | +$2.03 |
| Q3 2025 | $0.13 | +$2.41 |
| Q2 2025 | -$0.07 | +$2.35 |
| Q1 2025 | $0.15 | +$2.70 |
| Q4 2024 | -$2.36 | +$0.08 |
WHWK has swung to a loss: it lost $1.89 per share over the past year, after a profit the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over WHWK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
WHWK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $7.1M | +33% |
| Q4 2024 | $7.2M | +14% |
| Q3 2024 | $7.2M | +21% |
| Q2 2024 | $6.2M | -0.4% |
| Q1 2024 | $5.4M | -8.8% |
| Q4 2023 | $6.3M | +21% |
| Q3 2023 | $6M | +40% |
| Q2 2023 | $6.2M | +80% |
WHWK's revenue has slid since its 2020 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | -213% | +152 points |
| Q4 2024 | -262% | +18 points |
| Q3 2024 | -186% | +114 points |
| Q2 2024 | -252% | +63 points |
| Q1 2024 | -365% | -78 points |
| Q4 2023 | -280% | +16 points |
| Q3 2023 | -300% | +55 points |
| Q2 2023 | -315% | +219 points |
WHWK's operating margin was −213% last quarter, up 152 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over WHWK on cash generation, producing positive trailing cash flow while its opponent burns cash.
WHWK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.7M | -$4.3M |
| Q2 2026 | -$14.5M | +$38.4M |
| Q1 2026 | -$22.2M | -$9.8M |
| Q4 2025 | -$17.2M | -$2M |
| Q3 2025 | -$15.4M | +$497K |
| Q2 2025 | -$53M | -$43.3M |
| Q1 2025 | -$12.4M | +$8M |
| Q4 2024 | -$15.2M | -$4.8M |
WHWK has burned cash in almost every quarter: −$74M over the past year, against −$96M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over WHWK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
WHWK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +11M shares |
| 1 year | +36% | +24.8M shares |
| 3 years | +249% | +67M shares |
| 5 years | +3203% | +91M shares |
| Available history | +3369% | +91.2M shares |
WHWK has 94M diluted shares, up 36% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
WHWK Net Leverage
WHWK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
WHWK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 13.2 | Oversold |
WHWK's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
WHWK PE vs Healthcare Sector
| Metric | WHWK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WHWK has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over WHWK on trend strength, trading above more of its moving averages.
WHWK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.31 | 7.3% below |
| 20 week MA | $3.88 | 21% below |
| 50 week MA | $3.63 | 15% below |
| 100 week MA | $2.89 | 6.2% above |
| 200 week MA | $3.60 | 15% below |
WHWK's trend is mixed: it's above one of its five weekly moving averages, and 15% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over WHWK on returns for 2026, with the stronger performance.
WHWK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.0 | $25.9 | -0.6% |
| 2022 | $25.9 | $12.5 | -52% |
| 2023 | $12.5 | $2.02 | -84% |
| 2024 | $2.02 | $3.21 | +59% |
| 2025 | $3.21 | $2.67 | -17% |
| 2026 YTD | $2.67 | $3.07 | +15% |
WHWK has finished lower in four of the last five years. It's up 15% so far in 2026.